Delivery Order HHSN272201300022I-HHSN27200018
Award Date 3/2/17
Potential Completion Date 9/30/23
Potential Value $180K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $8,596,361.86 task order is for overall administration, clinical operations support, and concept and protocol development, implementation, and assays for the VTEU program. The prime contractor is the University of Maryland,...
- This is a $358,696 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The order supports a base award for HHSN272201300022I, with a total ceiling value of $1,033,104.95 and an ultimate completion date of July 11, 2023. The award does not have...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
- This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) contract, which is a multiple award indefinite delivery/indefinite quantity (IDIQ) contract managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $59,220 award was made to the University of Maryland, Baltimore (UMB) to provide vaccine treatment evaluation services as part of the...
- This is a delivery order awarded to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The task order, valued at $1,771,855.55, is for vaccine and treatment evaluation protocol development, implementation, and assays, as well as population pharmacokinetic analyses. UMB, as the prime...
- This is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery, Indefinite Quantity (IDIQ) contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Maryland, Baltimore (UMB). The $221,908.61 award supports the Vaccine Treatment Evaluation Units (VTEUS) program, which focuses on vaccine and treatment research for infectious diseases. The award does not include a set-aside designation. As a major public...
- This is a task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The $344,492 task order supports biomedical research activities under the VTEU program. The VTEU program is a major NIH initiative to conduct clinical trials and evaluations of vaccines and treatments for...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for overall administration, clinical operations support, and concept and protocol development, implementation and assays related to the Vaccine and Treatment Evaluation Units (VTEU) program. The contract has a ceiling value of $1,492,834.57 and runs from July 18, 2016 to July 14, 2021....
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle. The $488,933.02 award is for a cost-reimbursement contract with no fee to support VTEU activities. UMB, a major public research university, is serving as the prime contractor on this task order, which does not have a...
- The University of Maryland, Baltimore (UMB) was awarded a $991,159.60 delivery order contract by the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services. This award falls under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which supports vaccine treatment and evaluation research. The contract has no set-aside designation. The award provides funding for UMB to...
- HHSN272201300022IIndefinite Delivery Contract
- HHSN272201300022I-HHSN27200018Delivery Order
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract. The order is for VTEU protocol development, implementation, and assays under Task Areas B-D, with a period of performance through September 30, 2023 and a ceiling value of $180,225.65. UMB, as the prime contractor, will provide these biomedical research and development services related to vaccine and treatment evaluations for infectious diseases. This award does not have a set-aside designation.
Generated 4/2/25, 11:17 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 4/27/12, 1:53 PM | |
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 6/5/12, 2:56 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Close Out | ($37k) | 4/30/18 | |
| Not listed | Not listed | $217.5k | 3/2/17 |